Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Kurorti Akhtala | Healthcare Services | 0.9% | 25th pct | 268 |
| Potis Tsentraluri Saava… | Healthcare Services | -25.5% | 6th pct | 268 |
| Med Emergency | Healthcare Services | -130.5% | 2nd pct | 268 |
| Redi | Healthcare Services | — | no FY data | 268 |
| Akhali Samshobiaro Tsen… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 3 of 5 peers filed FY2024. Switch to FY2021 (4 of 5).
| Ratio — FY 2024 | Med Emergency | Kurorti Akhtala | Potis Tsentraluri Saava… | Redi | Akhali Samshobiaro Tsen… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 49.1% | 100.0% | 70.6% | — | — |
| EBITDA Margin | -130.5% | 0.9% | -25.5% | — | — |
| EBITDAR | -518 | 5 | -133 | — | — |
| EBITDAR Margin | -78.2% | 0.9% | -25.5% | — | — |
| EBIT Margin | -141.1% | -10.1% | -128.5% | — | — |
| Net Profit Margin | -141.1% | -27.0% | -130.6% | — | — |
| Operating Expense % of Sales | 179.6% | 99.1% | 96.0% | — | — |
| Returns | |||||
| Return on Assets (ROA) | -139.3% | -4.8% | -24.6% | — | — |
| Return on Equity (ROE) | N/A | -4.8% | N/A | — | — |
| ROIC [EBIT / Invested Capital] | N/A | -1.9% | -38.2% | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 102.7% | 0.0% | 102.0% | — | — |
| Debt-to-Equity | -0.42x | 0.00x | -2.66x | — | — |
| Debt-to-EBITDA | N/A | 0.00x | N/A | — | — |
| Equity-to-Assets | -241.9% | 99.9% | -38.4% | — | — |
| Net Debt | 667 | -130 | 2,831 | — | — |
| Cash & Equivalents | 22 | 130 | 10 | — | — |
| Total Debt | 689 | N/A | 2,840 | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 0.14x | 51.85x | 0.40x | — | — |
| Quick Ratio | 0.14x | 51.85x | 0.40x | — | — |
| Cash Ratio | 0.01x | 48.58x | 0.01x | — | — |
| Total Current Assets | 223 | 139 | 368 | — | — |
| Total Current Liabilities | 1,604 | 3 | 927 | — | — |
| Inventory | N/A | N/A | N/A | — | — |
| Trade Receivables | 186 | N/A | 358 | — | — |
| Trade Payables | 1,102 | 3 | 477 | — | — |
| Net Working Capital | -1,381 | 136 | -559 | — | — |
| Net Working Capital % of Revenue | -208.6% | 23.7% | -106.8% | — | — |
| Trade Working Capital | -916 | -3 | -119 | — | — |
| Trade Working Capital % of Revenue | -138.3% | -0.5% | -22.7% | — | — |
| Change in Trade Working Capital | N/A | N/A | N/A | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | N/A | N/A | — | — |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | — | — |
| Receivables Turnover | 3.56x | N/A | 1.46x | — | — |
| Days Sales Outstanding (DSO) | 102.6 | N/A | 249.8 | — | — |
| Payables Turnover | 0.31x | N/A | 0.32x | — | — |
| Days Payable Outstanding (DPO) | 1192.5 | N/A | 1130.1 | — | — |
| Cash Conversion Cycle | -1090.0 days | N/A | -880.3 days | — | — |
| Asset Turnover | 0.99x | 0.18x | 0.19x | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | -6 | -78 | 6 | — | — |
| Free Cash Flow (OCF − Capex proxy) | -6 | -113 | 6 | — | — |
| Cash Conversion (OCF / EBITDA) | N/A | -1594.1% | N/A | — | — |
| Dividends Declared | N/A | N/A | N/A | — | — |
| Dividend Payout Ratio | N/A | N/A | N/A | — | — |